Litcius/Paper detail

Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma

Weiqing Shao, Wenwei Zhu, Meng-Jun Luo, Ming-Hao Fan, Qin Li, Shenghao Wang, Zhifei Lin, Jing Zhao, Yan Zheng, Qiongzhu Dong, Lu Lu, Hu‐Liang Jia, Jubo Zhang, Ming Lü, Jinhong Chen, Lun–Xiu Qin

2022Cell Reports34 citationsDOIOpen Access PDF

Abstract

Aberrant activation of receptor tyrosine kinases (RTKs) and the subsequent metabolic reprogramming play critical roles in cancer progression. Our previous study has shown that Golgi membrane protein 1 (GOLM1) promotes hepatocellular carcinoma (HCC) metastasis by enhancing the recycling of RTKs. However, how this RTK recycling process is regulated and coupled with RTK degradation remains poorly defined. Here, we demonstrate that cholesterol suppresses the autophagic degradation of RTKs in a GOLM1-dependent manner. Further mechanistic studies reveal that GOLM1 mediates the selective autophagy of RTKs by interacting with LC3 through an LC3-interacting region (LIR), which is regulated by a cholesterol-mTORC1 axis. Lowering cholesterol by statins improves the efficacy of multiple tyrosine kinase inhibitors (TKIs) in vivo. Our findings indicate that cholesterol serves as a signal to switch GOLM1-RTK degradation to GOLM1-RTK recycling and suggest that lowering cholesterol by statin may be a promising combination strategy to improve the TKI efficiency in HCC.

Topics & Concepts

Receptor tyrosine kinaseCancer researchAutophagyChemistryStatinTyrosine kinaseCholesterolHepatocellular carcinomaCell biologyBiologyBiochemistrySignal transductionApoptosisAutophagy in Disease and TherapyEndoplasmic Reticulum Stress and DiseaseRNA modifications and cancer